
Ipamorelin
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
Ipamorelin is a synthetic pentapeptide growth-hormone secretagogue that acts as a selective agonist of the ghrelin receptor (GHS-R). It is prized in research for its selectivity: it stimulates growth-hormone release with minimal effect on cortisol, prolactin or other hormones, unlike earlier, less-specific secretagogues.
| Test | Result | Status |
|---|---|---|
| Purity | 99.05% | Passed ✓ |
| Weight | 5.06mg | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 98.3% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 99.1% | Passed ✓ |
Research Information
Ipamorelin is studied for its selective, pulsatile stimulation of growth-hormone release from the pituitary in cell and animal models. Because it produces a clean GH pulse without broad hormonal disruption, it is often used together with a GHRH analog to study synergistic GH secretion. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
Ipamorelin Research & Studies
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide classified as a growth-hormone secretagogue. It functions as a selective agonist at the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHS-R). In laboratory settings it is examined for its ability to elicit growth-hormone release while showing limited interaction with other pituitary axes. The compound is supplied exclusively for in-vitro and controlled laboratory research.
Mechanism of Action
Ipamorelin binds the GHS-R expressed on pituitary somatotrophs, triggering intracellular calcium mobilization and subsequent growth-hormone secretion. Unlike earlier non-selective secretagogues, it produces a discrete, pulsatile GH signal with negligible concurrent elevation of cortisol or prolactin in experimental models. This receptor selectivity allows researchers to isolate GH-axis responses without broad endocrine interference. Studies commonly pair it with GHRH analogs to explore synergistic pathway interactions.
Primary Areas of Research
Investigators employ Ipamorelin to characterize selective GH release kinetics in pituitary cell cultures and animal model systems. Research focuses on receptor pharmacology, signal transduction cascades, and the temporal profile of hormone pulses. The peptide is also used to examine how clean GH stimulation influences downstream markers of growth-factor pathways under controlled laboratory conditions. Comparative work with less-selective secretagogues highlights its utility for dissecting specific GHS-R contributions.
Key Research Findings
Published laboratory work demonstrates that Ipamorelin elicits robust GH secretion while leaving ACTH, cortisol, and prolactin largely unaffected in the model systems tested. Its short-acting, pulse-like profile has been documented in both isolated cell preparations and whole-animal endocrine studies. When co-administered with GHRH analogs, additive or synergistic GH responses are routinely observed, supporting its use in multi-ligand receptor studies. These properties make it a preferred tool for isolating GH-axis dynamics.
Research Handling & Considerations
Ipamorelin is provided as a research-grade peptide intended solely for in-vitro assays and laboratory animal models under institutional oversight. Standard peptide-handling practices apply: protect from light and moisture, reconstitute with appropriate sterile diluents, and store aliquots at recommended low temperatures. All experimental protocols must remain confined to non-clinical research environments. The material is not intended for any form of human or veterinary administration.
Frequently Asked Questions
Ipamorelin acts as a selective agonist of the ghrelin receptor (GHS-R) on pituitary cells, enabling focused study of growth-hormone release pathways.
Explore Other High-Purity Peptides

CJC-1295 (No DAC)

Sermorelin

Tesamorelin
